Therapeutic potential of dual CDK12 and 13 inhibition in colorectal cancer

被引：0
|
作者：
Altunel, Erdem
Zokaasadi, Mohammad
Somarelli, Jason A.
McCall, Shannon J.
Gultawatvichai, Patan
Whalen, Giles Francis
Pitarresi, Jason
Hsu, David S.
机构：
[1] UMass Chan Med Sch, Div Hematol Oncol, Dept Med, Worcester, MA USA
[2] Duke Univ, Div Med Oncol, Dept Med, Med Ctr, Durham, NC USA
[3] Duke Univ, Dept Pathol, Med Ctr, Durham, NC USA
[4] UMass Chan Med Sch, Div Surg Oncol, Dept Surg, Worcester, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15601
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
    Zhang, Tinghu
    Kwiatkowski, Nicholas
    Olson, Calla M.
    Dixon-Clarke, Sarah E.
    Abraham, Brian J.
    Greifenberg, Ann K.
    Ficarro, Scott B.
    Elkins, Jonathan M.
    Liang, Yanke
    Hannett, Nancy M.
    Manz, Theresa
    Hao, Mingfeng
    Bartkowiak, Bartlomiej
    Greenleaf, Arno L.
    Marto, Jarrod A.
    Geyer, Matthias
    Bullock, Alex N.
    Young, Richard A.
    Gray, Nathanael S.
    NATURE CHEMICAL BIOLOGY, 2016, 12 (10) : 876 - +
  • [42] CDK13 cooperates with CDK12 to control global RNA polymerase II processivity
    Fan, Zheng
    Devlin, Jennifer R.
    Hogg, Simon J.
    Doyle, Maria A.
    Harrison, Paul F.
    Todorovski, Izabela
    Cluse, Leonie A.
    Knight, Deborah A.
    Sandow, Jarrod J.
    Gregory, Gareth
    Fox, Andrew
    Beilharz, Traude H.
    Kwiatkowski, Nicholas
    Scott, Nichollas E.
    Vidakovic, Ana Tufegdzic
    Kelly, Gavin P.
    Svejstrup, Jesper Q.
    Geyer, Matthias
    Gray, Nathanael S.
    Vervoort, Stephin J.
    Johnstone, Ricky W.
    SCIENCE ADVANCES, 2020, 6 (18)
  • [43] Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value
    Pichaya Thanindratarn
    Dylan C. Dean
    Wenlong Feng
    Ran Wei
    Scott D. Nelson
    Francis J. Hornicek
    Zhenfeng Duan
    European Spine Journal, 2020, 29 : 3214 - 3228
  • [44] Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value
    Thanindratarn, Pichaya
    Dean, Dylan C.
    Feng, Wenlong
    Wei, Ran
    Nelson, Scott D.
    Hornicek, Francis J.
    Duan, Zhenfeng
    EUROPEAN SPINE JOURNAL, 2020, 29 (12) : 3214 - 3228
  • [45] Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
    Tinghu Zhang
    Nicholas Kwiatkowski
    Calla M Olson
    Sarah E Dixon-Clarke
    Brian J Abraham
    Ann K Greifenberg
    Scott B Ficarro
    Jonathan M Elkins
    Yanke Liang
    Nancy M Hannett
    Theresa Manz
    Mingfeng Hao
    Bartlomiej Bartkowiak
    Arno L Greenleaf
    Jarrod A Marto
    Matthias Geyer
    Alex N Bullock
    Richard A Young
    Nathanael S Gray
    Nature Chemical Biology, 2016, 12 : 876 - 884
  • [46] Dual inhibition of PARP and ATR induces homologous recombination repair deficiency and leads to synthetic lethality in prostate cancer with CDK12 alteration
    Akamatsu, Shusuke
    Kamiyama, Yuki
    Sunada, Takuro
    Hikami, Kensuke
    Fukui, Tomohiro
    Mizuno, Kei
    Sumiyoshi, Takayuki
    Goto, Takayuki
    Kobayashi, Takashi
    Sasanuma, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Lack of evidence for CDK12 as an ovarian cancer predisposing gene
    Eeckhoutte, Alexandre
    Saint-Ghislain, Mathilde
    Reverdy, Manon
    Raynal, Virginie
    Baulande, Sylvain
    Bataillon, Guillaume
    Golmard, Lisa
    Stoppa-Lyonnet, Dominique
    Popova, Tatiana
    Houdayer, Claude
    Manie, Elodie
    Stern, Marc-Henri
    FAMILIAL CANCER, 2020, 19 (03) : 203 - 209
  • [48] CDK12: A Potent Target and Biomarker for Human Cancer Therapy
    Liang, Shujing
    Hu, Lifang
    Wu, Zixiang
    Chen, Zhihao
    Liu, Shuyu
    Xu, Xia
    Qian, Airong
    CELLS, 2020, 9 (06) : 1 - 15
  • [49] Lack of evidence for CDK12 as an ovarian cancer predisposing gene
    Alexandre Eeckhoutte
    Mathilde Saint-Ghislain
    Manon Reverdy
    Virginie Raynal
    Sylvain Baulande
    Guillaume Bataillon
    Lisa Golmard
    Dominique Stoppa-Lyonnet
    Tatiana Popova
    Claude Houdayer
    Elodie Manié
    Marc-Henri Stern
    Familial Cancer, 2020, 19 : 203 - 209
  • [50] CDK12 null prostate cancer cell line LNCaP shows reduced growth potential
    Kamiyama, Yuki
    Akamatsu, Shusuke
    Sunada, Takuro
    Kouno, Yuka
    Kimura, Hiroko
    Lee, Xin
    Mizuno, Kei
    Matsuoka, Takashi
    Goto, Takayuki
    Kobayashi, Takashi
    Ogawa, Osamu
    CANCER SCIENCE, 2021, 112 : 846 - 846
12345